You are here

Enhancing adherence to behavioral change recommendations and medications among cancer survivors - Pravettoni

Enhancing adherence to behavioral change recommendations and medications among cancer survivors

Adherence to behavioral change recommendations and medications is far to be optimal in cancer survivors, contributing to adverse clinical events and increasing healthcare costs. A gold standard for assessing and improving adherence to pharmacological and non-pharmacological treatment is still missing for this kind of patients. The complexity of adherence results from an interplay of a constellation of factors including illness characteristics, patient views and psychological factors, social contexts, and healthcare aspects that need to be integrated into a unique model to address the issue of non-adherence holistically. Thus, it would be relevant to identify the most relevant determinants of patients’ adherence (patient-, doctor- and system-related factors) and develop personalized and effective interventions to foster compliance to medications and behavioral change recommendations.
The aim of this PhD project will be to:
1. Identify psychological and socio-economic risk factors and mechanisms of low adherence to pharmacological and behavioral change recommendations in cancer survivors.
2. Develop an agnostic model to predict adherence along the treatment trajectory.
3. Implement personalized and effective psycho-behavioral intervention to promote adherence to behavioral change recommendations and medications.
 
The candidate will be required to apply knowledge and expertise from psychological, cognitive and social domains to clinical care, using quantitative and qualitative methodology and conducting retrospective and prospective studies.